Friday, February 26, 2021
ADVT 
Health & Fitness

Study finds long-acting shot helps women avoid HIV infection

Darpan News Desk The Canadian Press, 10 Nov, 2020
  • Study finds long-acting shot helps women avoid HIV infection

Researchers are stopping a study early after finding that a shot of an experimental medicine every two months worked better than daily pills to help keep women from catching HIV from an infected sex partner.

The news is a boon for AIDS prevention efforts especially in Africa, where the study took place, and where women have few discreet ways of protecting themselves from infection.

Results so far suggest that the drug, cabotegravir, was 89% more effective at preventing HIV infection than Truvada pills, although both reduce that risk.

The results mirror those announced earlier this year from a similar study testing the shots versus the daily pills in gay men.

Cabotegravir is being developed by ViiV Healthcare, which is mostly owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited. The study was sponsored by the U.S. National Institutes of Health, the Bill and Melinda Gates Foundation and ViiV. The drugs were provided by ViiV and Truvada’s maker, Gilead Sciences.

“This is a major, major advance,” said Dr. Anthony Fauci, the top infectious disease doctor at the NIH. "I don’t think we can overemphasize the importance of this study.

It promises HIV prevention help to young women, “those who need it the most,” he said.

Young women may be twice as likely as men to get HIV in some areas of the world, according to one study leader, Sinead Delany-Moretlwe of the University of the Witwatersrand in Johannesburg, South Africa.

“They need discreet options ... without having to negotiate with their partners” to use measures such as condoms, said Deborah Waterhouse, of ViiV.

The study involved more than 3,200 participants in seven African countries who were randomly assigned to get either the shots every two months or daily Truvada pills. Independent monitors advised stopping the study after seeing that only 0.21% of women receiving the shots caught the AIDS virus versus 1.79% of women on the pills.

There were more side effects, mostly nausea, with the daily pills.

Cabotegravir's makers are seeking approval from regulators to sell it for this purpose, and Truvada already is widely used.

“The urgent work now” is to make all prevention medicines affordable and more widely available, said Mitchell Warren, who heads AVAC, formerly known as the AIDS Vaccine Advocacy Coalition, a non-profit focused on prevention efforts that had no role in the study.

Condoms remain widely recommended because they help prevent a host of sexually spread diseases, not just HIV.

“People need choices for HIV prevention,” and this gives a new option, Warren said in a statement.

MORE Health & Fitness ARTICLES

Cheap drug is first shown to improve COVID-19 survival

Cheap drug is first shown to improve COVID-19 survival

Researchers in England say they have the first evidence that a drug can improve COVID-19 survival: A cheap, widely available steroid reduced deaths by up to one third in severely ill hospitalized patients.

Cheap drug is first shown to improve COVID-19 survival

Simple Lifestyle Changes To Boost Your Immunity

Simple Lifestyle Changes To Boost Your Immunity

Many health experts have made claims that a strong immunity can lessen the chances of an individual getting infected by the novel coronavirus.&nbsp

Simple Lifestyle Changes To Boost Your Immunity

8 Tips to Reduce Your Stress

8 Tips to Reduce Your Stress

Maybe it’s a coworker. Perhaps it’s watching political news on television.Whatever is causing your stress, reduce the time you spend engaged with it. 

8 Tips to Reduce Your Stress

Airbnb, NYC agree to end their fight over host data-sharing

Airbnb, NYC agree to end their fight over host data-sharing

Airbnb and New York City will settle their fight over a law that sought to limit housing rental increases by requiring short-term rental platforms to share information about their listings, the two sides announced Friday.

Airbnb, NYC agree to end their fight over host data-sharing

Researchers ask if survivor plasma could prevent coronavirus

Researchers ask if survivor plasma could prevent coronavirus

Survivors of COVID-19 are donating their blood plasma in droves in hopes it helps other patients recover from the coronavirus. And while the jury’s still out, now scientists are testing if the donations might also prevent infection in the first place.

Researchers ask if survivor plasma could prevent coronavirus

Trump administration revokes transgender health protection

Trump administration revokes transgender health protection

The Trump administration Friday finalized a regulation that overturns Obama-era protections for transgender people against sex discrimination in health care.

Trump administration revokes transgender health protection